NCT07461584 Memory Enhancement in Aging With Optimal Dosing
| NCT ID | NCT07461584 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Boston University Charles River Campus |
| Condition | Aging |
| Study Type | INTERVENTIONAL |
| Enrollment | 240 participants |
| Start Date | 2026-06-01 |
| Primary Completion | 2031-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 240 participants in total. It began in 2026-06-01 with a primary completion date of 2031-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project optimizes high-resolution transcranial Alternating Current Stimulation (tACS) to improve memory in healthy older adults, advancing drug-free approaches for Alzheimer's disease and related dementia (ADRD). We test stimulation schedules and develop an adaptive, brain-guided tACS system to strengthen memory-supporting networks.
Eligibility Criteria
Inclusion Criteria: * 65 years of age or older * normal or corrected-to-normal vision * color vision Exclusion Criteria: * pregnant * metal implants in head * implanted electronic devices * history of neurological problems or head injury * skin sensitivity * claustrophobia * dementia (normal Montreal Cognitive Assessment \> 25) * depression (normal Geriatric Depression Scale \< 10) * history of psychosis * cognitive deficits (MoCA\>25) * any psychoactive medication
Contact & Investigator
Robert Reinhart, PhD
PRINCIPAL INVESTIGATOR
Boston University Charles River Campus
Frequently Asked Questions
Who can join the NCT07461584 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07461584 currently recruiting?
Yes, NCT07461584 is actively recruiting participants. Contact the research team at rmgr@bu.edu for enrollment information.
Where is the NCT07461584 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT07461584 clinical trial?
NCT07461584 is sponsored by Boston University Charles River Campus. The principal investigator is Robert Reinhart, PhD at Boston University Charles River Campus. The trial plans to enroll 240 participants.